OncoSec Medical Incorporated Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Equity Offerings (Details Narrative)

Equity Offerings (Details Narrative) - USD ($)						12 Months Ended
Equity Offerings (Details Narrative) - USD ($)	Jul. 31, 2017	Jul. 25, 2017	May 26, 2016	Nov. 09, 2015	Jun. 08, 2015	Jul. 31, 2017	Jul. 31, 2016
Warrant to purchase shares of common stock	9,044,740					9,044,740
Number of common stock shares issued	21,618,194					21,618,194	18,036,263
Fair value of warrants			$ 4,400,000
Warrants outstanding	$ 11,775,807					$ 11,775,807	$ 13,288,527
Series B [Member]
Warrants outstanding	$ 900,000					$ 900,000
Maximum [Member]
Warrant exercise price per share	$ 18.00					$ 18.00
Warrant expiry date	Sep. 30, 2017
Minimum [Member]
Warrant exercise price per share	$ 0.01					$ 0.01
Warrant expiry date	May 31, 2025
Equity Distribution Agreement [Member] \| Oppenheimer & Co. Inc [Member] \| Maximum [Member]
Aggregate gross sales price		$ 8,400,000
October 22, 2017 [Member] \| Equity Distribution Agreement [Member] \| Oppenheimer & Co. Inc [Member] \| Maximum [Member]
Other expenses						$ 1,100,000
October 2017 Offerings [Member] \| Placement Agent [Member] \| October 25, 2017 [Member]
Warrant expiry date						Oct. 21, 2022
May 2016 Offering [Member]
Gross proceeds from offering			9,900,000
Net proceeds from offering			$ 9,200,000
Number of common stock shares issued			665,049
May 2016 Offering [Member] \| Placement Agents [Member]
Warrant to purchase shares of common stock			275,482
Warrant exercise price per share			$ 2.26875
Warrant expiry date			May 24, 2021
May 2016 Offering [Member] \| Series A [Member]
Warrant to purchase shares of common stock			5,509,642
Purchase price per share			$ 1.815
Warrant exercise price per share			$ 1.69
Warrant term			9 years
Dividend rate			0.00%
Expected term of volatility			9 years
Volatility rate			100.03%
Risk-free interest rate			1.74%
Fair value assumption market value			$ 48,446
May 2016 Offering [Member] \| Series B [Member]
Warrant to purchase shares of common stock			4,844,593
Purchase price per share			$ 1.805
Warrant exercise price per share			$ 0.01
November 2015 Offering [Member]
Warrant to purchase shares of common stock				1,071,430
Purchase price per share				$ 3.50
Warrant exercise price per share				$ 4.50
Gross proceeds from offering				$ 7,500,000
Net proceeds from offering				$ 6,900,000
Warrant expiry date				May 09, 2021
Number of common stock shares issued				2,142,860
Fair value of warrants				$ 1,600,000
Dividend rate				0.00%
Expected term of volatility				5 years 18 days
Volatility rate				88.63%
Risk-free interest rate				1.75%
Placement agent fees as a percentage of gross proceeds				6.00%
Non-accountable expense allowance as a percentage of gross proceeds of offering				1.00%
November 2015 Offering [Member] \| Placement Agents [Member]
Warrant to purchase shares of common stock				107,143
Warrant exercise price per share				$ 4.375
Warrant expiry date				Nov. 09, 2020
Warrant term				5 years
Fair value of warrants				$ 200,000
Dividend rate				0.00%
Expected term of volatility				5 years
Volatility rate				89.08%
Risk-free interest rate				1.75%
June 2015 Public Offering [Member]
Warrant to purchase shares of common stock					123,455
Purchase price per share					$ 5.50
Warrant exercise price per share					$ 6.88
Gross proceeds from offering					$ 13,600,000
Net proceeds from offering					$ 12,500,000
Warrant expiry date					May 12, 2019
Number of common stock shares issued					2,469,091
June 2015 Public Offering [Member] \| Placement Agents [Member]
Fair value of warrants					$ 600,000
Dividend rate					0.00%
Expected term of volatility					5 years
Volatility rate					88.40%
Risk-free interest rate					1.72%